简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-12-02 18:57 GVK BIO Announces Launch of a GMP Compliant Analytical Services Laboratory
2016-12-02 15:54 QuintilesIMS Named Best Full-service Provider CRO in 2016 Scrip Awards
2016-12-02 10:35 Cook Medical Opens New Distribution Centre in Singapore
2016-12-01 14:50 Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany
2016-12-01 14:19 Patient Safety Movement Foundation Names Dr. Jannicke Mellin-Olsen to Its Board of Directors
2016-12-01 11:24 Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos Collaborate on Nanotechnology R&D Platform
2016-11-29 09:27 Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss
2016-11-28 17:38 NINLARO™ (ixazomib) Receives Conditional Approval from the European Commission to Treat Multiple Myeloma
2016-11-23 13:26 Provata Health Launches Groundbreaking Virtual Reality Guided Meditation App
2016-11-17 10:51 On World Prematurity Day, UNICEF emphasizes use of cost-effective interventions to improve survival of premature and low-birthweight babies
2016-11-17 10:09 Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin®
2016-11-17 10:05 Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within 2017 GOLD Strategy for COPD
2016-11-16 17:28 Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment
2016-11-16 17:18 Updated Phase III Results Reinforce Safety and Efficacy of Praxbind® (idarucizumab) in Urgent Situations
2016-11-15 17:57 Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients
2016-11-15 15:49 MetLife Hong Kong Launches Unique Overseas Medical Treatment Insurance Plan
2016-11-15 14:35 New landmark study reveals adults with diabetes at unnecessary risk of vision loss
2016-11-15 10:02 Data on Early Onset of Efficacy for Oral OTEZLA® (apremilast) in Active Psoriatic Arthritis Presented at American College of Rheumatology
2016-11-14 16:29 Jardiance® (empagliflozin) consistently reduced the risk of cardiovascular death in adults with type 2 diabetes regardless of the type of cardiovascular disease at baseline
2016-11-14 16:05 MetLife Hong Kong Promotes Hereditary Cancer Awareness with Sponsorship of Pink Heels Race 2016

Business Wire Weibo

Press Releases

Latest Releases